Global Cancer Oncology Testing Market Growth (Status and Outlook) 2026-2032
The global Cancer Oncology Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Cancer Oncology Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cancer Oncology Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cancer Oncology Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cancer Oncology Testing players cover Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Cancer Oncology Testing Industry Forecast” looks at past sales and reviews total world Cancer Oncology Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Cancer Oncology Testing sales for 2026 through 2032. With Cancer Oncology Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Oncology Testing industry.
This Insight Report provides a comprehensive analysis of the global Cancer Oncology Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cancer Oncology Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Oncology Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Oncology Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Oncology Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Oncology Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Cancer Oncology Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cancer Oncology Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cancer Oncology Testing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cancer Oncology Testing players cover Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Cancer Oncology Testing Industry Forecast” looks at past sales and reviews total world Cancer Oncology Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Cancer Oncology Testing sales for 2026 through 2032. With Cancer Oncology Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Oncology Testing industry.
This Insight Report provides a comprehensive analysis of the global Cancer Oncology Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cancer Oncology Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Oncology Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Oncology Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Oncology Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Oncology Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Fluorescence In Situ Hybridization
- Polymerase Chain Reaction
- Microarray Technology
- Serum Proteomics
- Nucleic Acid Sequencing
- Hospitals
- Speciality Clinics
- Research Institutes
- Diagnostics Laboratories
- Biopharmaceutical Companies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Devyser
- Agendia
- Illumina
- Personal Genome Diagnostics
- Veracyte
- Pacific Biosciences of California
- Qiagen
- Agilent Technologies
- Natera
- Bio Rad Laboratories
- Myriad Genetics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Oncology Testing Market Size (2021-2032)
2.1.2 Cancer Oncology Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cancer Oncology Testing by Country/Region (2021, 2025 & 2032)
2.2 Cancer Oncology Testing Segment by Type
2.2.1 Fluorescence In Situ Hybridization
2.2.2 Polymerase Chain Reaction
2.2.3 Microarray Technology
2.2.4 Serum Proteomics
2.2.5 Nucleic Acid Sequencing
2.2.6 Cancer Oncology Testing Market Size by Type
2.2.6.1 Cancer Oncology Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
2.3 Cancer Oncology Testing Segment by Application
2.3.1 Hospitals
2.3.2 Speciality Clinics
2.3.3 Research Institutes
2.3.4 Diagnostics Laboratories
2.3.5 Biopharmaceutical Companies
2.3.6 Cancer Oncology Testing Market Size by Application
2.3.6.1 Cancer Oncology Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
3 CANCER ONCOLOGY TESTING MARKET SIZE BY PLAYER
3.1 Cancer Oncology Testing Market Size Market Share by Player
3.1.1 Global Cancer Oncology Testing Revenue by Player (2021-2026)
3.1.2 Global Cancer Oncology Testing Revenue Market Share by Player (2021-2026)
3.2 Global Cancer Oncology Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER ONCOLOGY TESTING BY REGION
4.1 Cancer Oncology Testing Market Size by Region (2021-2026)
4.2 Global Cancer Oncology Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cancer Oncology Testing Market Size Growth (2021-2026)
4.4 APAC Cancer Oncology Testing Market Size Growth (2021-2026)
4.5 Europe Cancer Oncology Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Cancer Oncology Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cancer Oncology Testing Market Size by Country (2021-2026)
5.2 Americas Cancer Oncology Testing Market Size by Type (2021-2026)
5.3 Americas Cancer Oncology Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Oncology Testing Market Size by Region (2021-2026)
6.2 APAC Cancer Oncology Testing Market Size by Type (2021-2026)
6.3 APAC Cancer Oncology Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Oncology Testing Market Size by Country (2021-2026)
7.2 Europe Cancer Oncology Testing Market Size by Type (2021-2026)
7.3 Europe Cancer Oncology Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Oncology Testing by Region (2021-2026)
8.2 Middle East & Africa Cancer Oncology Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Cancer Oncology Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER ONCOLOGY TESTING MARKET FORECAST
10.1 Global Cancer Oncology Testing Forecast by Region (2027-2032)
10.1.1 Global Cancer Oncology Testing Forecast by Region (2027-2032)
10.1.2 Americas Cancer Oncology Testing Forecast
10.1.3 APAC Cancer Oncology Testing Forecast
10.1.4 Europe Cancer Oncology Testing Forecast
10.1.5 Middle East & Africa Cancer Oncology Testing Forecast
10.2 Americas Cancer Oncology Testing Forecast by Country (2027-2032)
10.2.1 United States Market Cancer Oncology Testing Forecast
10.2.2 Canada Market Cancer Oncology Testing Forecast
10.2.3 Mexico Market Cancer Oncology Testing Forecast
10.2.4 Brazil Market Cancer Oncology Testing Forecast
10.3 APAC Cancer Oncology Testing Forecast by Region (2027-2032)
10.3.1 China Cancer Oncology Testing Market Forecast
10.3.2 Japan Market Cancer Oncology Testing Forecast
10.3.3 Korea Market Cancer Oncology Testing Forecast
10.3.4 Southeast Asia Market Cancer Oncology Testing Forecast
10.3.5 India Market Cancer Oncology Testing Forecast
10.3.6 Australia Market Cancer Oncology Testing Forecast
10.4 Europe Cancer Oncology Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Cancer Oncology Testing Forecast
10.4.2 France Market Cancer Oncology Testing Forecast
10.4.3 UK Market Cancer Oncology Testing Forecast
10.4.4 Italy Market Cancer Oncology Testing Forecast
10.4.5 Russia Market Cancer Oncology Testing Forecast
10.5 Middle East & Africa Cancer Oncology Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Cancer Oncology Testing Forecast
10.5.2 South Africa Market Cancer Oncology Testing Forecast
10.5.3 Israel Market Cancer Oncology Testing Forecast
10.5.4 Turkey Market Cancer Oncology Testing Forecast
10.6 Global Cancer Oncology Testing Forecast by Type (2027-2032)
10.7 Global Cancer Oncology Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cancer Oncology Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Devyser
11.1.1 Devyser Company Information
11.1.2 Devyser Cancer Oncology Testing Product Offered
11.1.3 Devyser Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Devyser Main Business Overview
11.1.5 Devyser Latest Developments
11.2 Agendia
11.2.1 Agendia Company Information
11.2.2 Agendia Cancer Oncology Testing Product Offered
11.2.3 Agendia Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Agendia Main Business Overview
11.2.5 Agendia Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Cancer Oncology Testing Product Offered
11.3.3 Illumina Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Personal Genome Diagnostics
11.4.1 Personal Genome Diagnostics Company Information
11.4.2 Personal Genome Diagnostics Cancer Oncology Testing Product Offered
11.4.3 Personal Genome Diagnostics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Personal Genome Diagnostics Main Business Overview
11.4.5 Personal Genome Diagnostics Latest Developments
11.5 Veracyte
11.5.1 Veracyte Company Information
11.5.2 Veracyte Cancer Oncology Testing Product Offered
11.5.3 Veracyte Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Veracyte Main Business Overview
11.5.5 Veracyte Latest Developments
11.6 Pacific Biosciences of California
11.6.1 Pacific Biosciences of California Company Information
11.6.2 Pacific Biosciences of California Cancer Oncology Testing Product Offered
11.6.3 Pacific Biosciences of California Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pacific Biosciences of California Main Business Overview
11.6.5 Pacific Biosciences of California Latest Developments
11.7 Qiagen
11.7.1 Qiagen Company Information
11.7.2 Qiagen Cancer Oncology Testing Product Offered
11.7.3 Qiagen Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Qiagen Main Business Overview
11.7.5 Qiagen Latest Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Information
11.8.2 Agilent Technologies Cancer Oncology Testing Product Offered
11.8.3 Agilent Technologies Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Agilent Technologies Main Business Overview
11.8.5 Agilent Technologies Latest Developments
11.9 Natera
11.9.1 Natera Company Information
11.9.2 Natera Cancer Oncology Testing Product Offered
11.9.3 Natera Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Natera Main Business Overview
11.9.5 Natera Latest Developments
11.10 Bio Rad Laboratories
11.10.1 Bio Rad Laboratories Company Information
11.10.2 Bio Rad Laboratories Cancer Oncology Testing Product Offered
11.10.3 Bio Rad Laboratories Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Bio Rad Laboratories Main Business Overview
11.10.5 Bio Rad Laboratories Latest Developments
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Information
11.11.2 Myriad Genetics Cancer Oncology Testing Product Offered
11.11.3 Myriad Genetics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Myriad Genetics Main Business Overview
11.11.5 Myriad Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Oncology Testing Market Size (2021-2032)
2.1.2 Cancer Oncology Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cancer Oncology Testing by Country/Region (2021, 2025 & 2032)
2.2 Cancer Oncology Testing Segment by Type
2.2.1 Fluorescence In Situ Hybridization
2.2.2 Polymerase Chain Reaction
2.2.3 Microarray Technology
2.2.4 Serum Proteomics
2.2.5 Nucleic Acid Sequencing
2.2.6 Cancer Oncology Testing Market Size by Type
2.2.6.1 Cancer Oncology Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
2.3 Cancer Oncology Testing Segment by Application
2.3.1 Hospitals
2.3.2 Speciality Clinics
2.3.3 Research Institutes
2.3.4 Diagnostics Laboratories
2.3.5 Biopharmaceutical Companies
2.3.6 Cancer Oncology Testing Market Size by Application
2.3.6.1 Cancer Oncology Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
3 CANCER ONCOLOGY TESTING MARKET SIZE BY PLAYER
3.1 Cancer Oncology Testing Market Size Market Share by Player
3.1.1 Global Cancer Oncology Testing Revenue by Player (2021-2026)
3.1.2 Global Cancer Oncology Testing Revenue Market Share by Player (2021-2026)
3.2 Global Cancer Oncology Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER ONCOLOGY TESTING BY REGION
4.1 Cancer Oncology Testing Market Size by Region (2021-2026)
4.2 Global Cancer Oncology Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cancer Oncology Testing Market Size Growth (2021-2026)
4.4 APAC Cancer Oncology Testing Market Size Growth (2021-2026)
4.5 Europe Cancer Oncology Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Cancer Oncology Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cancer Oncology Testing Market Size by Country (2021-2026)
5.2 Americas Cancer Oncology Testing Market Size by Type (2021-2026)
5.3 Americas Cancer Oncology Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Oncology Testing Market Size by Region (2021-2026)
6.2 APAC Cancer Oncology Testing Market Size by Type (2021-2026)
6.3 APAC Cancer Oncology Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Oncology Testing Market Size by Country (2021-2026)
7.2 Europe Cancer Oncology Testing Market Size by Type (2021-2026)
7.3 Europe Cancer Oncology Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Oncology Testing by Region (2021-2026)
8.2 Middle East & Africa Cancer Oncology Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Cancer Oncology Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER ONCOLOGY TESTING MARKET FORECAST
10.1 Global Cancer Oncology Testing Forecast by Region (2027-2032)
10.1.1 Global Cancer Oncology Testing Forecast by Region (2027-2032)
10.1.2 Americas Cancer Oncology Testing Forecast
10.1.3 APAC Cancer Oncology Testing Forecast
10.1.4 Europe Cancer Oncology Testing Forecast
10.1.5 Middle East & Africa Cancer Oncology Testing Forecast
10.2 Americas Cancer Oncology Testing Forecast by Country (2027-2032)
10.2.1 United States Market Cancer Oncology Testing Forecast
10.2.2 Canada Market Cancer Oncology Testing Forecast
10.2.3 Mexico Market Cancer Oncology Testing Forecast
10.2.4 Brazil Market Cancer Oncology Testing Forecast
10.3 APAC Cancer Oncology Testing Forecast by Region (2027-2032)
10.3.1 China Cancer Oncology Testing Market Forecast
10.3.2 Japan Market Cancer Oncology Testing Forecast
10.3.3 Korea Market Cancer Oncology Testing Forecast
10.3.4 Southeast Asia Market Cancer Oncology Testing Forecast
10.3.5 India Market Cancer Oncology Testing Forecast
10.3.6 Australia Market Cancer Oncology Testing Forecast
10.4 Europe Cancer Oncology Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Cancer Oncology Testing Forecast
10.4.2 France Market Cancer Oncology Testing Forecast
10.4.3 UK Market Cancer Oncology Testing Forecast
10.4.4 Italy Market Cancer Oncology Testing Forecast
10.4.5 Russia Market Cancer Oncology Testing Forecast
10.5 Middle East & Africa Cancer Oncology Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Cancer Oncology Testing Forecast
10.5.2 South Africa Market Cancer Oncology Testing Forecast
10.5.3 Israel Market Cancer Oncology Testing Forecast
10.5.4 Turkey Market Cancer Oncology Testing Forecast
10.6 Global Cancer Oncology Testing Forecast by Type (2027-2032)
10.7 Global Cancer Oncology Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cancer Oncology Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Devyser
11.1.1 Devyser Company Information
11.1.2 Devyser Cancer Oncology Testing Product Offered
11.1.3 Devyser Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Devyser Main Business Overview
11.1.5 Devyser Latest Developments
11.2 Agendia
11.2.1 Agendia Company Information
11.2.2 Agendia Cancer Oncology Testing Product Offered
11.2.3 Agendia Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Agendia Main Business Overview
11.2.5 Agendia Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Cancer Oncology Testing Product Offered
11.3.3 Illumina Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Personal Genome Diagnostics
11.4.1 Personal Genome Diagnostics Company Information
11.4.2 Personal Genome Diagnostics Cancer Oncology Testing Product Offered
11.4.3 Personal Genome Diagnostics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Personal Genome Diagnostics Main Business Overview
11.4.5 Personal Genome Diagnostics Latest Developments
11.5 Veracyte
11.5.1 Veracyte Company Information
11.5.2 Veracyte Cancer Oncology Testing Product Offered
11.5.3 Veracyte Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Veracyte Main Business Overview
11.5.5 Veracyte Latest Developments
11.6 Pacific Biosciences of California
11.6.1 Pacific Biosciences of California Company Information
11.6.2 Pacific Biosciences of California Cancer Oncology Testing Product Offered
11.6.3 Pacific Biosciences of California Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pacific Biosciences of California Main Business Overview
11.6.5 Pacific Biosciences of California Latest Developments
11.7 Qiagen
11.7.1 Qiagen Company Information
11.7.2 Qiagen Cancer Oncology Testing Product Offered
11.7.3 Qiagen Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Qiagen Main Business Overview
11.7.5 Qiagen Latest Developments
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Information
11.8.2 Agilent Technologies Cancer Oncology Testing Product Offered
11.8.3 Agilent Technologies Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Agilent Technologies Main Business Overview
11.8.5 Agilent Technologies Latest Developments
11.9 Natera
11.9.1 Natera Company Information
11.9.2 Natera Cancer Oncology Testing Product Offered
11.9.3 Natera Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Natera Main Business Overview
11.9.5 Natera Latest Developments
11.10 Bio Rad Laboratories
11.10.1 Bio Rad Laboratories Company Information
11.10.2 Bio Rad Laboratories Cancer Oncology Testing Product Offered
11.10.3 Bio Rad Laboratories Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Bio Rad Laboratories Main Business Overview
11.10.5 Bio Rad Laboratories Latest Developments
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Information
11.11.2 Myriad Genetics Cancer Oncology Testing Product Offered
11.11.3 Myriad Genetics Cancer Oncology Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Myriad Genetics Main Business Overview
11.11.5 Myriad Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cancer Oncology Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cancer Oncology Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fluorescence In Situ Hybridization
Table 4. Major Players of Polymerase Chain Reaction
Table 5. Major Players of Microarray Technology
Table 6. Major Players of Serum Proteomics
Table 7. Major Players of Nucleic Acid Sequencing
Table 8. Cancer Oncology Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cancer Oncology Testing Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
Table 11. Cancer Oncology Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Cancer Oncology Testing Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
Table 14. Global Cancer Oncology Testing Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Cancer Oncology Testing Revenue Market Share by Player (2021-2026)
Table 16. Cancer Oncology Testing Key Players Head office and Products Offered
Table 17. Cancer Oncology Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Cancer Oncology Testing Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Cancer Oncology Testing Market Size Market Share by Region (2021-2026)
Table 22. Global Cancer Oncology Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Cancer Oncology Testing Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Cancer Oncology Testing Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Cancer Oncology Testing Market Size Market Share by Country (2021-2026)
Table 26. Americas Cancer Oncology Testing Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
Table 28. Americas Cancer Oncology Testing Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
Table 30. APAC Cancer Oncology Testing Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Cancer Oncology Testing Market Size Market Share by Region (2021-2026)
Table 32. APAC Cancer Oncology Testing Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Cancer Oncology Testing Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Cancer Oncology Testing Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Cancer Oncology Testing Market Size Market Share by Country (2021-2026)
Table 36. Europe Cancer Oncology Testing Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Cancer Oncology Testing Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Cancer Oncology Testing Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Cancer Oncology Testing Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Cancer Oncology Testing Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Cancer Oncology Testing
Table 42. Key Market Challenges & Risks of Cancer Oncology Testing
Table 43. Key Industry Trends of Cancer Oncology Testing
Table 44. Global Cancer Oncology Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Cancer Oncology Testing Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Cancer Oncology Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Cancer Oncology Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Devyser Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 49. Devyser Cancer Oncology Testing Product Offered
Table 50. Devyser Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Devyser Main Business
Table 52. Devyser Latest Developments
Table 53. Agendia Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 54. Agendia Cancer Oncology Testing Product Offered
Table 55. Agendia Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Agendia Main Business
Table 57. Agendia Latest Developments
Table 58. Illumina Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 59. Illumina Cancer Oncology Testing Product Offered
Table 60. Illumina Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Illumina Main Business
Table 62. Illumina Latest Developments
Table 63. Personal Genome Diagnostics Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 64. Personal Genome Diagnostics Cancer Oncology Testing Product Offered
Table 65. Personal Genome Diagnostics Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Personal Genome Diagnostics Main Business
Table 67. Personal Genome Diagnostics Latest Developments
Table 68. Veracyte Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 69. Veracyte Cancer Oncology Testing Product Offered
Table 70. Veracyte Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Veracyte Main Business
Table 72. Veracyte Latest Developments
Table 73. Pacific Biosciences of California Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 74. Pacific Biosciences of California Cancer Oncology Testing Product Offered
Table 75. Pacific Biosciences of California Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Pacific Biosciences of California Main Business
Table 77. Pacific Biosciences of California Latest Developments
Table 78. Qiagen Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 79. Qiagen Cancer Oncology Testing Product Offered
Table 80. Qiagen Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Qiagen Main Business
Table 82. Qiagen Latest Developments
Table 83. Agilent Technologies Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 84. Agilent Technologies Cancer Oncology Testing Product Offered
Table 85. Agilent Technologies Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Agilent Technologies Main Business
Table 87. Agilent Technologies Latest Developments
Table 88. Natera Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 89. Natera Cancer Oncology Testing Product Offered
Table 90. Natera Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Natera Main Business
Table 92. Natera Latest Developments
Table 93. Bio Rad Laboratories Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 94. Bio Rad Laboratories Cancer Oncology Testing Product Offered
Table 95. Bio Rad Laboratories Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Bio Rad Laboratories Main Business
Table 97. Bio Rad Laboratories Latest Developments
Table 98. Myriad Genetics Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 99. Myriad Genetics Cancer Oncology Testing Product Offered
Table 100. Myriad Genetics Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Myriad Genetics Main Business
Table 102. Myriad Genetics Latest Developments
Table 1. Cancer Oncology Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cancer Oncology Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fluorescence In Situ Hybridization
Table 4. Major Players of Polymerase Chain Reaction
Table 5. Major Players of Microarray Technology
Table 6. Major Players of Serum Proteomics
Table 7. Major Players of Nucleic Acid Sequencing
Table 8. Cancer Oncology Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cancer Oncology Testing Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
Table 11. Cancer Oncology Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Cancer Oncology Testing Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
Table 14. Global Cancer Oncology Testing Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Cancer Oncology Testing Revenue Market Share by Player (2021-2026)
Table 16. Cancer Oncology Testing Key Players Head office and Products Offered
Table 17. Cancer Oncology Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Cancer Oncology Testing Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Cancer Oncology Testing Market Size Market Share by Region (2021-2026)
Table 22. Global Cancer Oncology Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Cancer Oncology Testing Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Cancer Oncology Testing Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Cancer Oncology Testing Market Size Market Share by Country (2021-2026)
Table 26. Americas Cancer Oncology Testing Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
Table 28. Americas Cancer Oncology Testing Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
Table 30. APAC Cancer Oncology Testing Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Cancer Oncology Testing Market Size Market Share by Region (2021-2026)
Table 32. APAC Cancer Oncology Testing Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Cancer Oncology Testing Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Cancer Oncology Testing Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Cancer Oncology Testing Market Size Market Share by Country (2021-2026)
Table 36. Europe Cancer Oncology Testing Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Cancer Oncology Testing Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Cancer Oncology Testing Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Cancer Oncology Testing Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Cancer Oncology Testing Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Cancer Oncology Testing
Table 42. Key Market Challenges & Risks of Cancer Oncology Testing
Table 43. Key Industry Trends of Cancer Oncology Testing
Table 44. Global Cancer Oncology Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Cancer Oncology Testing Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Cancer Oncology Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Cancer Oncology Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Devyser Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 49. Devyser Cancer Oncology Testing Product Offered
Table 50. Devyser Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Devyser Main Business
Table 52. Devyser Latest Developments
Table 53. Agendia Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 54. Agendia Cancer Oncology Testing Product Offered
Table 55. Agendia Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Agendia Main Business
Table 57. Agendia Latest Developments
Table 58. Illumina Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 59. Illumina Cancer Oncology Testing Product Offered
Table 60. Illumina Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Illumina Main Business
Table 62. Illumina Latest Developments
Table 63. Personal Genome Diagnostics Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 64. Personal Genome Diagnostics Cancer Oncology Testing Product Offered
Table 65. Personal Genome Diagnostics Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Personal Genome Diagnostics Main Business
Table 67. Personal Genome Diagnostics Latest Developments
Table 68. Veracyte Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 69. Veracyte Cancer Oncology Testing Product Offered
Table 70. Veracyte Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Veracyte Main Business
Table 72. Veracyte Latest Developments
Table 73. Pacific Biosciences of California Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 74. Pacific Biosciences of California Cancer Oncology Testing Product Offered
Table 75. Pacific Biosciences of California Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Pacific Biosciences of California Main Business
Table 77. Pacific Biosciences of California Latest Developments
Table 78. Qiagen Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 79. Qiagen Cancer Oncology Testing Product Offered
Table 80. Qiagen Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Qiagen Main Business
Table 82. Qiagen Latest Developments
Table 83. Agilent Technologies Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 84. Agilent Technologies Cancer Oncology Testing Product Offered
Table 85. Agilent Technologies Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Agilent Technologies Main Business
Table 87. Agilent Technologies Latest Developments
Table 88. Natera Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 89. Natera Cancer Oncology Testing Product Offered
Table 90. Natera Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Natera Main Business
Table 92. Natera Latest Developments
Table 93. Bio Rad Laboratories Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 94. Bio Rad Laboratories Cancer Oncology Testing Product Offered
Table 95. Bio Rad Laboratories Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Bio Rad Laboratories Main Business
Table 97. Bio Rad Laboratories Latest Developments
Table 98. Myriad Genetics Details, Company Type, Cancer Oncology Testing Area Served and Its Competitors
Table 99. Myriad Genetics Cancer Oncology Testing Product Offered
Table 100. Myriad Genetics Cancer Oncology Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Myriad Genetics Main Business
Table 102. Myriad Genetics Latest Developments
LIST OF FIGURES
Figure 1. Cancer Oncology Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Oncology Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cancer Oncology Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cancer Oncology Testing Sales Market Share by Country/Region (2025)
Figure 8. Cancer Oncology Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cancer Oncology Testing Market Size Market Share by Type in 2025
Figure 10. Cancer Oncology Testing in Hospitals
Figure 11. Global Cancer Oncology Testing Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Cancer Oncology Testing in Speciality Clinics
Figure 13. Global Cancer Oncology Testing Market: Speciality Clinics (2021-2026) & ($ millions)
Figure 14. Cancer Oncology Testing in Research Institutes
Figure 15. Global Cancer Oncology Testing Market: Research Institutes (2021-2026) & ($ millions)
Figure 16. Cancer Oncology Testing in Diagnostics Laboratories
Figure 17. Global Cancer Oncology Testing Market: Diagnostics Laboratories (2021-2026) & ($ millions)
Figure 18. Cancer Oncology Testing in Biopharmaceutical Companies
Figure 19. Global Cancer Oncology Testing Market: Biopharmaceutical Companies (2021-2026) & ($ millions)
Figure 20. Global Cancer Oncology Testing Market Size Market Share by Application in 2025
Figure 21. Global Cancer Oncology Testing Revenue Market Share by Player in 2025
Figure 22. Global Cancer Oncology Testing Market Size Market Share by Region (2021-2026)
Figure 23. Americas Cancer Oncology Testing Market Size 2021-2026 ($ millions)
Figure 24. APAC Cancer Oncology Testing Market Size 2021-2026 ($ millions)
Figure 25. Europe Cancer Oncology Testing Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Cancer Oncology Testing Market Size 2021-2026 ($ millions)
Figure 27. Americas Cancer Oncology Testing Value Market Share by Country in 2025
Figure 28. United States Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Cancer Oncology Testing Market Size Market Share by Region in 2025
Figure 33. APAC Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
Figure 34. APAC Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
Figure 35. China Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. India Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Cancer Oncology Testing Market Size Market Share by Country in 2025
Figure 42. Europe Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
Figure 43. Europe Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
Figure 44. Germany Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. France Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Cancer Oncology Testing Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 58. APAC Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 59. Europe Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 61. United States Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 62. Canada Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 63. Mexico Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 64. Brazil Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 65. China Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 66. Japan Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 67. Korea Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 69. India Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 70. Australia Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 71. Germany Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 72. France Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 73. UK Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 74. Italy Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 75. Russia Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 76. Egypt Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 77. South Africa Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 78. Israel Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 79. Turkey Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 80. Global Cancer Oncology Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Cancer Oncology Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 1. Cancer Oncology Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Oncology Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cancer Oncology Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cancer Oncology Testing Sales Market Share by Country/Region (2025)
Figure 8. Cancer Oncology Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cancer Oncology Testing Market Size Market Share by Type in 2025
Figure 10. Cancer Oncology Testing in Hospitals
Figure 11. Global Cancer Oncology Testing Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Cancer Oncology Testing in Speciality Clinics
Figure 13. Global Cancer Oncology Testing Market: Speciality Clinics (2021-2026) & ($ millions)
Figure 14. Cancer Oncology Testing in Research Institutes
Figure 15. Global Cancer Oncology Testing Market: Research Institutes (2021-2026) & ($ millions)
Figure 16. Cancer Oncology Testing in Diagnostics Laboratories
Figure 17. Global Cancer Oncology Testing Market: Diagnostics Laboratories (2021-2026) & ($ millions)
Figure 18. Cancer Oncology Testing in Biopharmaceutical Companies
Figure 19. Global Cancer Oncology Testing Market: Biopharmaceutical Companies (2021-2026) & ($ millions)
Figure 20. Global Cancer Oncology Testing Market Size Market Share by Application in 2025
Figure 21. Global Cancer Oncology Testing Revenue Market Share by Player in 2025
Figure 22. Global Cancer Oncology Testing Market Size Market Share by Region (2021-2026)
Figure 23. Americas Cancer Oncology Testing Market Size 2021-2026 ($ millions)
Figure 24. APAC Cancer Oncology Testing Market Size 2021-2026 ($ millions)
Figure 25. Europe Cancer Oncology Testing Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Cancer Oncology Testing Market Size 2021-2026 ($ millions)
Figure 27. Americas Cancer Oncology Testing Value Market Share by Country in 2025
Figure 28. United States Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Cancer Oncology Testing Market Size Market Share by Region in 2025
Figure 33. APAC Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
Figure 34. APAC Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
Figure 35. China Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. India Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Cancer Oncology Testing Market Size Market Share by Country in 2025
Figure 42. Europe Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
Figure 43. Europe Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
Figure 44. Germany Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. France Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Cancer Oncology Testing Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Cancer Oncology Testing Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Cancer Oncology Testing Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Cancer Oncology Testing Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 58. APAC Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 59. Europe Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 61. United States Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 62. Canada Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 63. Mexico Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 64. Brazil Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 65. China Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 66. Japan Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 67. Korea Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 69. India Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 70. Australia Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 71. Germany Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 72. France Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 73. UK Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 74. Italy Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 75. Russia Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 76. Egypt Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 77. South Africa Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 78. Israel Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 79. Turkey Cancer Oncology Testing Market Size 2027-2032 ($ millions)
Figure 80. Global Cancer Oncology Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Cancer Oncology Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Cancer Oncology Testing Market Size 2027-2032 ($ millions)
